Hap Trading, LLC Brainstorm Cell Therapeutics Inc. Transaction History
Hap Trading, LLC
- $1.15 Trillion
- Q4 2024
A detailed history of Hap Trading, LLC transactions in Brainstorm Cell Therapeutics Inc. stock. As of the latest transaction made, Hap Trading, LLC holds 10,400 shares of BCLI stock, worth $9,152. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,400Holding current value
$9,152% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding BCLI
# of Institutions
9Shares Held
549KCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY386KShares$340,0440.0% of portfolio
-
Raymond James & Associates St Petersburg, FL95.2KShares$83,7340.0% of portfolio
-
Liberty Wealth Management LLC Oakland, CA22.7KShares$19,9460.01% of portfolio
-
Weaver Consulting Group15.6KShares$13,7480.01% of portfolio
-
S.C. Financial Services, Inc.12.7KShares$11,1630.03% of portfolio
About BRAINSTORM CELL THERAPEUTICS INC.
- Ticker BCLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,486,200
- Market Cap $32.1M
- Description
- Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...